WEP Clinical
↗Morrisville, USA
WEP Clinical is a specialist services company and Contract Research Organization (CRO) that partners with drug developers to provide early access to medicines for patients with unmet needs. The company specializes in the design and management of Expanded Access Programs (EAPs), Named Patient Programs (NPPs), and full-service clinical trial management from Phase I to IV.
Founded in 2008, WEP Clinical has evolved into a 'Complete CRO' through strategic acquisitions and organic growth. The company provides end-to-end solutions including clinical trial sourcing, regulatory guidance, and commercialization strategies, with a particular focus on complex therapeutic areas such as oncology and rare diseases.
CLASSIFICATION
Company Type:CRO
Industry:Pharmaceuticals
Sub-Industry:Contract Research Organization (CRO) / Expanded Access
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:2008
Ownership:private
Status:operating
FUNDING
Stage:Late Stage (PE-backed)
Total Raised:Undisclosed
Investors:TJC (The Jordan Company)
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Cell therapy, Gene therapy, Vaccines
Active Trials:60
Trial Phases:Phase 1: 15 | Phase 2: 20 | Phase 3: 20 | Phase 4: 5
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Siron Clinical, Wren Healthcare, WE PHARMA (Belgium)
Key Partnerships:TaiMed Biologics (Expanded Access Program), Theratechnologies (Named Patient Program), Medlab Clinical (CBD product distribution)
COMPETITION
Position:Leader in Expanded Access and Niche CRO services
Competitors:Clinigen, Veristat, Tanner Pharma Group, Bionical, IPG (International Pharma Services)
LEADERSHIP
Key Executives:
Jaswinder Khera - CEO
Shaheen Limbada - Chief Operating Officer
Karl Challender - Chief Financial Officer
Scientific Founders:Jaswinder Khera, Jaswant Khera
Board Members:Jaswant Khera
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with WEP Clinical. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.